Technical Analysis for NBTX - Nanobiotix S.A.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 6.90 | 7.64% | 0.49 |
NBTX closed up 7.64 percent on Wednesday, May 8, 2024, on 1.12 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 15
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Centerline Cross | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Gap Up Closed | about 19 hours ago |
| Outside Day | about 19 hours ago |
| Fell Below Previous Day's Low | about 19 hours ago |
| Upper Bollinger Band Resistance | about 19 hours ago |
| Reversed from Up | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.
The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.
Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.0 |
| 52 Week Low | 4.55 |
| Average Volume | 21,667 |
| 200-Day Moving Average | 7.11 |
| 50-Day Moving Average | 6.20 |
| 20-Day Moving Average | 5.90 |
| 10-Day Moving Average | 6.11 |
| Average True Range | 0.35 |
| RSI (14) | 67.43 |
| ADX | 28.56 |
| +DI | 39.75 |
| -DI | 11.20 |
| Chandelier Exit (Long, 3 ATRs) | 5.85 |
| Chandelier Exit (Short, 3 ATRs) | 6.18 |
| Upper Bollinger Bands | 6.63 |
| Lower Bollinger Band | 5.18 |
| Percent B (%b) | 1.19 |
| BandWidth | 24.60 |
| MACD Line | 0.07 |
| MACD Signal Line | -0.07 |
| MACD Histogram | 0.1354 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.65 | ||||
| Resistance 3 (R3) | 7.57 | 7.23 | 7.53 | ||
| Resistance 2 (R2) | 7.23 | 7.04 | 7.28 | 7.48 | |
| Resistance 1 (R1) | 7.07 | 6.92 | 7.15 | 7.15 | 7.44 |
| Pivot Point | 6.73 | 6.73 | 6.78 | 6.78 | 6.73 |
| Support 1 (S1) | 6.57 | 6.54 | 6.65 | 6.65 | 6.36 |
| Support 2 (S2) | 6.23 | 6.42 | 6.28 | 6.32 | |
| Support 3 (S3) | 6.07 | 6.23 | 6.28 | ||
| Support 4 (S4) | 6.15 |
